Sumatriptan succinate injectable
Closed Pre-Solicitation Posted
- Solicitation number
- SPE2D217R0032
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
Notice text
7 versions
Update #7 · Latest ·
SUMATRIPTAN SUCCINATE INJECTABLE
Modification P00007 to Invoke Option 4 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Modification P00006 to Invoke Option 3 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Modification P00005 SPE2D218D0053 Price change for Sumagriptan Succinate 6MG/0.5ML Vial (5 Vials/PK)
Modification P00004 SPE2D218D0053 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Modification P00003 to Invoke Option 2 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Update #6 ·
SUMATRIPTAN SUCCINATE INJECTABLE
Modification P00006 to Invoke Option 3 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Modification P00005 SPE2D218D0053 Price change for Sumagriptan Succinate 6MG/0.5ML Vial (5 Vials/PK)
Modification P00004 SPE2D218D0053 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Modification P00003 to Invoke Option 2 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Update #5 ·
SUMATRIPTAN SUCCINATE INJECTABLE
Modification P00005 SPE2D218D0053 Price change for Sumagriptan Succinate 6MG/0.5ML Vial (5 Vials/PK)
Modification P00004 SPE2D218D0053 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Modification P00003 to Invoke Option 2 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Update #4 ·
SUMATRIPTAN SUCCINATE INJECTABLE
Modification P00004 SPE2D218D0053 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Modification P00003 to Invoke Option 2 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Update #3 ·
SUMATRIPTAN SUCCINATE INJECTABLE
Modification P00003 to Invoke Option 2 - Sumatriptan Succinate (Injectable) SPE2D2-18-D-0053.
Update #2 ·
SUMATRIPTAN SUCCINATE INJECTABLE
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Sumatriptan Succinate Injectable. Procurement details follow.
Sumatriptan Succinate (injectable) 6MG/0.5ML PEN INJCTR (KIT = 2VIALS/KIT) and 6MG/0.5ML VIAL (PACK= 5 VIALS/PK). This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Phyllis Daraio (215)737-7941 email Phyllis.Daraio@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is October of 2017. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
Show all 11
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity